Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders

Yan Cai,1 Seong Soo A An,1 SangYun Kim2 1Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, 2Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea Abstract: Alzh...

Full description

Bibliographic Details
Main Authors: Cai Y, An SSA, Kim SY
Format: Article
Language:English
Published: Dove Medical Press 2015-07-01
Series:Clinical Interventions in Aging
Subjects:
Online Access:https://www.dovepress.com/mutations-in-presenilin-2-and-its-implications-in-alzheimerrsquos-dise-peer-reviewed-article-CIA
_version_ 1818743302714818560
author Cai Y
An SSA
Kim SY
author_facet Cai Y
An SSA
Kim SY
author_sort Cai Y
collection DOAJ
description Yan Cai,1 Seong Soo A An,1 SangYun Kim2 1Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, 2Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea Abstract: Alzheimer’s disease (AD) is the most common form of dementia. Mutations in the genes encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have been identified as the main genetic causes of familial AD. To date, more than 200 mutations have been described worldwide in PSEN1, which is highly homologous with PSEN2, while mutations in PSEN2 have been rarely reported. We performed a systematic review of studies describing the mutations identified in PSEN2. Most PSEN2 mutations were detected in European and in African populations. Only two were found in Korean populations. Interestingly, PSEN2 mutations appeared not only in AD patients but also in patients with other disorders, including frontotemporal dementia, dementia with Lewy bodies, breast cancer, dilated cardiomyopathy, and Parkinson’s disease with dementia. Here, we have summarized the PSEN2 mutations and the potential implications of these mutations in dementia-associated disorders. Keywords: mutations in presenilin 2, Alzheimer’s disease
first_indexed 2024-12-18T02:26:15Z
format Article
id doaj.art-40b9f8b4c33540fbae3385fd083e204a
institution Directory Open Access Journal
issn 1178-1998
language English
last_indexed 2024-12-18T02:26:15Z
publishDate 2015-07-01
publisher Dove Medical Press
record_format Article
series Clinical Interventions in Aging
spelling doaj.art-40b9f8b4c33540fbae3385fd083e204a2022-12-21T21:24:01ZengDove Medical PressClinical Interventions in Aging1178-19982015-07-01Volume 101163117222605Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disordersCai YAn SSAKim SYYan Cai,1 Seong Soo A An,1 SangYun Kim2 1Department of Bionano Technology, Gachon Medical Research Institute, Gachon University, 2Department of Neurology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, South Korea Abstract: Alzheimer’s disease (AD) is the most common form of dementia. Mutations in the genes encoding presenilin 1 (PSEN1), presenilin 2 (PSEN2), and amyloid precursor protein have been identified as the main genetic causes of familial AD. To date, more than 200 mutations have been described worldwide in PSEN1, which is highly homologous with PSEN2, while mutations in PSEN2 have been rarely reported. We performed a systematic review of studies describing the mutations identified in PSEN2. Most PSEN2 mutations were detected in European and in African populations. Only two were found in Korean populations. Interestingly, PSEN2 mutations appeared not only in AD patients but also in patients with other disorders, including frontotemporal dementia, dementia with Lewy bodies, breast cancer, dilated cardiomyopathy, and Parkinson’s disease with dementia. Here, we have summarized the PSEN2 mutations and the potential implications of these mutations in dementia-associated disorders. Keywords: mutations in presenilin 2, Alzheimer’s diseasehttps://www.dovepress.com/mutations-in-presenilin-2-and-its-implications-in-alzheimerrsquos-dise-peer-reviewed-article-CIApresenilin 2mutationAlzheimer's disease
spellingShingle Cai Y
An SSA
Kim SY
Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
Clinical Interventions in Aging
presenilin 2
mutation
Alzheimer's disease
title Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_full Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_fullStr Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_full_unstemmed Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_short Mutations in presenilin 2 and its implications in Alzheimer’s disease and other dementia-associated disorders
title_sort mutations in presenilin 2 and its implications in alzheimer rsquo s disease and other dementia associated disorders
topic presenilin 2
mutation
Alzheimer's disease
url https://www.dovepress.com/mutations-in-presenilin-2-and-its-implications-in-alzheimerrsquos-dise-peer-reviewed-article-CIA
work_keys_str_mv AT caiy mutationsinpresenilin2anditsimplicationsinalzheimerrsquosdiseaseandotherdementiaassociateddisorders
AT anssa mutationsinpresenilin2anditsimplicationsinalzheimerrsquosdiseaseandotherdementiaassociateddisorders
AT kimsy mutationsinpresenilin2anditsimplicationsinalzheimerrsquosdiseaseandotherdementiaassociateddisorders